Serum Erythropoietin (EPO)
30.4-kDa glycoprotein hormone produced by peritubular interstitial fibroblasts in the renal cortex in response to tissue hypoxia.
Standard vs. Optimal Reference RangesmIU/mL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
4.0 - 24.0 mIU/mL
General reference distribution across unselected commercial populations.
5.0 - 18.0 mIU/mL
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Induced by hypoxia-inducible factor 2-alpha (HIF-2alpha); binds EPO receptors on erythroid progenitors in bone marrow to prevent apoptosis.
Differential Diagnosis
Elevated Levels (EPO High)
- •Secondary polycythemia (chronic hypoxia, obstructive sleep apnea, high altitude, EPO-secreting renal tumors)
- •Severe anemia (compensatory surge)
Low Levels (EPO Low)
- •Polycythemia Vera (JAK2 V617F mutation, autonomous erythropoiesis with suppressed EPO <4.0)
- •Chronic kidney disease anemia (loss of peritubular fibroblasts)
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for EPO
- Targeted organ system imaging or functional dynamic testing related to renal hypoxia & erythropoiesis
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Serum Erythropoietin - The New England Journal of Medicine (2021). PMID: 34090124
- [2]EPO Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Serum Erythropoietin (EPO) into overall healthspan optimization.